DCD Renal Transplantation From Donors With Acute Kidney Injury.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
01 04 2021
Historique:
pubmed: 21 5 2020
medline: 27 7 2021
entrez: 21 5 2020
Statut: ppublish

Résumé

Deceased donor kidneys with acute kidney injury (AKI) and donation after circulatory death (DCD) kidneys are viable sources of organs. The outcomes of renal transplantation from DCD donors with AKI are not known. A retrospective review of deceased donor renal transplants performed from 2006 to 2016 was conducted using the United Network for Organ Sharing dataset. Donors were stratified by DCD or brain dead status and by AKI stage. Recipients were followed until graft failure or the end of study. Cox regression was used to adjust for donor, recipient, and transplant covariates known to affect the incidence of delayed graft function and graft survival. A total of 135 644 patients were included in the study. The odds of delayed graft function among DCD recipients were significantly higher across all donor AKI stages. The unadjusted risk of overall and death-censored graft failure were similar between the 2 groups. After adjusting for covariates, there was a significant increase in the risk of overall graft failure in recipients of DCD allografts from donors with stage 2 AKI. There was also a higher risk of death-censored graft failure among stage 1 and 2 AKI DCD recipients. DCD renal allografts from donors experiencing stage 1 and 2 AKI have a higher adjusted risk of death-censored graft failure than AKI stage-matched donation after brain death renal allografts. Their use, however, is still associated with improved outcomes compared with waitlist mortality.

Sections du résumé

BACKGROUND
Deceased donor kidneys with acute kidney injury (AKI) and donation after circulatory death (DCD) kidneys are viable sources of organs. The outcomes of renal transplantation from DCD donors with AKI are not known.
METHODS
A retrospective review of deceased donor renal transplants performed from 2006 to 2016 was conducted using the United Network for Organ Sharing dataset. Donors were stratified by DCD or brain dead status and by AKI stage. Recipients were followed until graft failure or the end of study. Cox regression was used to adjust for donor, recipient, and transplant covariates known to affect the incidence of delayed graft function and graft survival.
RESULTS
A total of 135 644 patients were included in the study. The odds of delayed graft function among DCD recipients were significantly higher across all donor AKI stages. The unadjusted risk of overall and death-censored graft failure were similar between the 2 groups. After adjusting for covariates, there was a significant increase in the risk of overall graft failure in recipients of DCD allografts from donors with stage 2 AKI. There was also a higher risk of death-censored graft failure among stage 1 and 2 AKI DCD recipients.
CONCLUSIONS
DCD renal allografts from donors experiencing stage 1 and 2 AKI have a higher adjusted risk of death-censored graft failure than AKI stage-matched donation after brain death renal allografts. Their use, however, is still associated with improved outcomes compared with waitlist mortality.

Identifiants

pubmed: 32433240
pii: 00007890-202104000-00028
doi: 10.1097/TP.0000000000003317
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

886-890

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no funding or conflicts of interest.

Références

Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341:1725–1730
Bae S, Massie AB, Luo X, et al. Changes in discard rate after the introduction of the kidney donor profile index (KDPI). Am J Transplant. 2016; 16:2202–2207
Organ procurement and transplantation network: Guide to calculating and interpreting the KDPI. Available from: https://optn.transplant.hrsa.gov/media/1512/guide_to_calculating_interpreting_kdpi.pdf . Accessed May 8, 2020
Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009; 88:231–236
Gentil MA, Castro P, Ballesteros L, et al. Survival of kidney allograft of donors after circulatory death is similar to donors after brain death: experience in a regional program. Transplant Proc. 2015; 47:2572–2574
Jochmans I, Darius T, Kuypers D, et al. Kidney donation after circulatory death in a country with a high number of brain dead donors: 10-year experience in Belgium. Transpl Int. 2012; 25:857–866
Weber M, Dindo D, Demartines N, et al. Kidney transplantation from donors without a heartbeat. N Engl J Med. 2002; 347:248–255
Boffa C, van de Leemkolk F, Curnow E, et al. Transplantation of kidneys from donors with acute kidney injury: friend or foe? Am J Transplant. 2017; 17:411–419
Merion RM, Ashby VB, Wolfe RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA. 2005; 294:2726–2733
Kayler LK, Garzon P, Magliocca J, et al. Outcomes and utilization of kidneys from deceased donors with acute kidney injury. Am J Transplant. 2009; 9:367–373
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury NetworkAcute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11:R31
Irish WD, Ilsley JN, Schnitzler MA, et al. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant. 2010; 10:2279–2286
Irish WD, McCollum DA, Tesi RJ, et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol. 2003; 14:2967–2974
Asher J, Wilson C, Gok M, et al. Factors predicting duration of delayed graft function in non-heart-beating donor kidney transplantation. Transplant Proc. 2005; 37:348–349
Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant. 2011; 11:2279–2296
Jadlowiec CC, Heilman RL, Smith ML, et al. Transplanting kidneys from donation after cardiac death donors with acute kidney injury. Am J Transplant. 2020; 20:864–869
Hall IE, Parikh CR, Schröppel B, et al. Procurement biopsy findings versus kidney donor risk index for predicting renal allograft survival. Transplant Direct. 2018; 4:e373
Carpenter D, Husain SA, Brennan C, et al. Procurement biopsies in the evaluation of deceased donor kidneys. Clin J Am Soc Nephrol. 2018; 13:1876–1885
Scalea JR, Redfield RR, Arpali E, et al. Does DCD donor time-to-death affect recipient outcomes? Implications of time-to-death at a high-volume center in the United States. Am J Transplant. 2017; 17:191–200
Law J, Hornby K, Payne C, et al. Missed opportunities for DCD kidney donors: evaluation of warm ischemic time and associated functional warm ischemic time. Clin Transplant. 2019; 33:e13724
Saran R, Robinson B, Abbott KC, et al. US renal data system 2018 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019; 73Suppl 1Svii-Sxxii–S1-S772
Reese PP, Shults J, Bloom RD, et al. Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates. Am J Kidney Dis. 2015; 66:837–845

Auteurs

Daniel Lia (D)

Division of Transplant Surgery, Department of Surgery, Northwell Health, Manhasset, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH